Ronny Gal, incoming Novartis chief strategy & growth officer
After a long run observing Novartis and the rest of the Big Pharma world as a top analyst, Bernstein’s Ronny Gal will now move into the upper echelon of the Swiss giant’s executive crew to take command of their newly integrated strategy and growth team.
Novartis CEO Vas Narasimhan announced the move early Tuesday with the Q1 numbers, with the company highlighting the role Gal will play directing deals, building the pipeline and prioritizing programs while positioning the company in a new approach aimed at significantly improving on their runner-up status in the all-important US market.
Related Post
The Path From College to Career
Career offices are seeking ways to prepare students for a rapidly changing work force.
11Another country just joined the space race… – The Horn News
South Korea joined the stampede to the moon Thursday with the launch of a lunar orbiter that will scout out future landing spots. The satellite launched by SpaceX is taking a long, roundabout path to…
12‘Deepest image of our universe’ ever taken by Webb Telescope will be revealed in July
By Ashley Strickland, CNN We’re about to have an entirely new perspective on the universe. The James Webb Space Telescope will release its first high-resolution color images on July 12. One of those…
13An uncomfortable question when you least expect it
When you’re in an exam room with a patient, sometimes you’re forced to contemplate uncomfortable questions.
14Where Does Wall Street Think Novartis AG (NVS) Stock Will Go?
Where Does Wall Street Think Novartis AG (NVS) Stock Will Go?
15